pub201957 Article

cited authors

  • Hall, William A; Pugh, Stephanie L; Wefel, Jeffrey S; Armstrong, Terri S; Gilbert, Mark R; Brachman, David G; Werner-Wasik, Maria; Wendland, Merideth M; Brown, Paul D; Chao, Samuel T; Roof, Kevin S; Robins, H Ian; Mehta, Minesh P; Curran, Walter J; Movsas, Benjamin

fiu authors

publication date

  • January 1, 2019

keywords

  • ADJUVANT TEMOZOLOMIDE
  • BEVACIZUMAB
  • Clinical Neurology
  • EXTENT
  • Glioblastoma and extent of resection
  • Glioblastoma and surgical resection
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • PRIMARY BRAIN
  • QUALITY-OF-LIFE
  • Resection extent and neurocognitive function
  • Resection status and quality of life
  • SURVIVAL
  • Science & Technology
  • Surgery
  • TRIALS
  • patient reported outcomes GBM

start page

  • 66

volume

  • 84